Form 8-K Shattuck Labs, Inc. For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
H.C. Wainwright Downgrades Shattuck Labs (STTK) to Neutral
October 1, 2024 10:32 AM EDTH.C. Wainwright analyst Joseph Pantginis downgraded Shattuck Labs (NASDAQ: STTK) from Buy to Neutral.
The analyst comments "Despite encouraging early clinical data; shifting gears away from CD47. This morning, Shattuck announced that following a strategic review of its pipeline and its amassed CD47 data to date in... More
H.C. Wainwright Downgrades Shattuck Labs (STTK) to Neutral
October 1, 2024 10:32 AM EDTH.C. Wainwright analyst Joseph Pantginis downgraded Shattuck Labs (NASDAQ: STTK) from Buy to Neutral.
The analyst comments "Despite encouraging early clinical data; shifting gears away from CD47. This morning, Shattuck announced that following a strategic review of its pipeline and its amassed CD47 data to date in... More
